NCT00491673

Brief Summary

There is increasing evidence that primary hemiarthroplasty is the treatment of choice for displaced femoral neck fractures in the elderly No definite conclusions have been made in regards to what kind of arthroplasty is favourable Cemented implants are associated with increased risk of perioperative cardiovascular incidents and increased mortality. Cementless implants are associated with increased postoperative pain and decreased walking ability. This study investigates the differences between one well-documented cemented femoral stem and one well-documented uncemented femoral stem. Previous studies have mostly used uncemented stems with different designs. Null hypothesis: No (less than 10 points) difference in HHS between groups at 1 year and 5 years

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
230

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2004

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2004

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

June 25, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 26, 2007

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
Last Updated

September 24, 2010

Status Verified

September 1, 2010

Enrollment Period

6.3 years

First QC Date

June 25, 2007

Last Update Submit

September 23, 2010

Conditions

Keywords

FractureFemoral neckArthroplasty

Outcome Measures

Primary Outcomes (1)

  • Functional outcome including pain (Harris Hip Score)

    5 years

Secondary Outcomes (4)

  • All Cause Mortality

    5 years

  • Activities Of Daily Living (Barthels ADL-Index)

    5 years

  • Quality Of Life (EQ-5D)

    5 years

  • Any treatment related complication

    5 years

Study Arms (2)

Uncemented

ACTIVE COMPARATOR

Uncemented primary bipolar hemiarthroplasty of the hip

Procedure: Uncemented primary bipolar hemiarthroplasty of the hip

Cemented

ACTIVE COMPARATOR

Cemented primary bipolar hemiarthroplasty of the hip

Procedure: Cemented primary bipolar hemiarthroplasty of the hip

Interventions

Uncemented primary bipolar hemiarthroplasty of the hip

Also known as: Corail, DePuy/Johnson and Johnson, United Kingdom
Uncemented

Cemented primary bipolar hemiarthroplasty of the hip

Also known as: Spectron, Smith & Nephew, Memphis, TN
Cemented

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Dislocated intracapsular femoral neck fracture
  • ≥ 70 years old

You may not qualify if:

  • Pathological fracture
  • Systemic or local infection
  • Short life expectancy/not mobile at all
  • Symptomatic coxarthrosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ullevål University Hospital

Oslo, Oslo County, 0407, Norway

Location

Sykehuset Asker And Baerum

Oslo, Rud, 1309, Norway

Location

Related Links

MeSH Terms

Conditions

Femoral Neck FracturesFractures, Bone

Condition Hierarchy (Ancestors)

Hip FracturesFemoral FracturesWounds and InjuriesHip InjuriesLeg Injuries

Study Officials

  • Lars Nordsletten, Prof MD PhD

    Ullevål University Hospital, University of Oslo

    STUDY CHAIR
  • Wender Figved, MD, PhD

    Asker and Baerum Hospital

    PRINCIPAL INVESTIGATOR
  • Lars Nordsletten, Prof MD PhD

    Ullevål University Hospital, University of Oslo

    STUDY DIRECTOR
  • Ellen Langslet, MD

    Ullevaal University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 25, 2007

First Posted

June 26, 2007

Study Start

September 1, 2004

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

September 24, 2010

Record last verified: 2010-09

Locations